About Aerami Therapeutics
Aerami Therapeutics is breathing life into the treatment of serious and rare cardiopulmonary conditions with a mission-driven objective: develop products that help patients live longer and help them live better. We do this by combining precision medicines and advanced administration platforms that support ease-of-use and quality-of-life.
Our lead program, AER-901 (inhaled imatinib) in pulmonary hypertension, has been intentionally designed to potentially reverse the damage caused by disease progression while overcoming many of the limitations of oral, parenteral, and other inhaled delivery technologies.
To learn more, visit: https://aerami.com/
#Aerami #Cardiopulmonary #PulmonaryHypertension #PulmonaryArterialHypertension #PH #PAH #ILD #HeartDisease #LungDisease #InhaledTherapeutics #AER901 #AER601
|
|
|
11-50 employees
View all Aerami Therapeutics employees
|
|
Biotechnology
|
|
2520 Meridian Pkwy, Durham, North Carolina, 27713, US
|
|
2010
|
Search Aerami Therapeutics Staff Directory
Find accurate personal emails, work emails and phone numbers for employees
Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut
Find countless prospects outside of LinkedIn fast
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.
